Alvotech and fuji pharma expand partnership adding a new biosimilar candidate

Alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and japanese pharmaceutical company fuji pharma co., ltd. (“fuji”, tokyo stock exchange: 4554) have decided to expand their existing exclusive commercialization partnership covering japan, by adding a new undisclosed biosimilar candidate.
ALVO Ratings Summary
ALVO Quant Ranking